The clinical management of neuropathic pain

Pain Research and Management

Volumn 11, Issue SUPPL. A, 2006, Pages

  Moulin, Dwight E ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Neuropathic pain; Pharmacological management

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUPRENORPHINE; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; DESIPRAMINE; DULOXETINE; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LIDOCAINE; METHADONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; OXYCODONE; PAROXETINE; PHENYTOIN; PLACEBO; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ALLODYNIA; ANALGESIA; ANALGESIC ACTIVITY; ANTICHOLINERGIC EFFECT; ATAXIA; BLURRED VISION; CHRONIC PAIN; CLINICAL FEATURE; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONFUSION; CONSTIPATION; DIABETIC NEUROPATHY; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DROWSINESS; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG INDUCED HEADACHE; ELECTROMYOGRAPHY; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HUMAN; NAUSEA; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; NEUROPATHOLOGY; ORTHOSTATIC HYPOTENSION; PAIN; PERIPHERAL EDEMA; PERIPHERAL NERVE INJURY; PHYSICAL EXAMINATION; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SIDE EFFECT; SOMNOLENCE; TRIGEMINUS NEURALGIA; UNSPECIFIED SIDE EFFECT; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

EID: 34147198012     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/359752     Document Type: Review

References (66)

1. Merskey H, Bogduk N, eds. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd edn. Seattle: IASP Press, 1994:209-14.
2. Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH. Association of pain relief with drug side effects in postherpetic neuralgia: A single dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmacol Ther 1988;43:363-71.
3. Low PA. Symptomatic treatment of painful neuropathy. JAMA 1998;280:1863-4.
4. Stevens PE, Dibble SL, Miaskowski C. Prevalence, characteristics, and impact of postmastectomy pain syndrome: An investigation of women's experiences. Pain 1995;61:61-8.
5. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med 2003;348:1279-81.
6. Bennett GJ. Neuropathic pain: New insights, new interventions. Hosp Pract 1998;33:95-8, 101-4.
7. Herbst RS, Bajorin DF, Bleiberg H, et al. Clinical cancer advances 2005: Major research advances in cancer treatment, prevention and screening - a report from the American Society of Clinical Oncology. J Clin Oncol 2006:24:190-205.
8. Harden RN, Bruehl SP. Diagnostic criteria: The statistical derivation of the four criterion factors. CRPS: Current diagnosis and therapy. In: Wilson P, Stanton-Hicks M, Harden RN, eds. Progress in Pain Research and Management. Seattle: IASP Press, 2005;32:45-58.
9. Woolf CJ, Mannion RD. Neuropathic pain: Aetiology, symptoms, mechanisms and management. Lancet 1999;353:1959-64.
10. Devor M, Lomazov P, Matzner O. Sodium channel accumulation in injured axons as a substrate for neuropathic pain. In: Boivie J, Hansson P, Lindblom U, eds. Progress in Pain Research and Management. Seattle: IASP Press, 1994;3:207-30.
11. Matthews EA, Dickenson AH. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 2001,92:235-46.
12. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005,114:29-36.
13. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997;73:123-39.
14. McQuay JH, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-27.
15. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000;55:915-20.
16. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
17. Sindrup SH, Gram LF, Brsen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135-44.
18. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin uptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52:547-52.
19. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999;83;389-400.
20. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: An evidence-based proposal. Pain 2005;118:289-305.
21. Rull JA, Quibrera R, Gonzalez-Millan H, et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): Double-blind crossover trial. Diabetologia 1969;5:215-8.
22. Chadda VS, Mathur MS. Double-blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India 1978;26:403-6.
23. Bryans JS, Wustrow DJ. 3-substituted GABA analogs with central nervous system activity: A review. Med Res Rev 1999;19:149-77.
24. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain. Arch Neurology 2003;60:1524-34.
25. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful diabetic neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831-6.
26. Rowbotham MC, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia. JAMA 1998;280:1837-42.
27. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003;60:1274-83.
28. Sabatowski R, Galvez R, Cherry DA, et al. 1008-045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in controlled clinical trial. Pain 2004;109:26-35.
29. Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. J Pain 2005;6:253-60.
30. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology 2004;63:2104-10.
31. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pan 2004:110:628-38.
32. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible - and fixed-dose regimens. Pain 2005;115:254-63.
33. Siddall J, Cousins MJ, Otte A, et al. Pregabalin safely and efficaciously treats chronic central neuropathic pain after spinal cord injury. J Pain 2005;6:S25.
34. Lunardi G, Leandri M, Albano C, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997;48:1714-7.
35. Eisenberg E, Luria Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology 2001;57:505-9.
36. McCleane G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: A randomized, double-blind, placebo-controlled trial. Pain 1999;83:105-7.
37. Dellmijn PLI. Are opioids effective in relieving neuropathic pain? Pain 1999;80:453-62.
38. Portenoy RK, Foley KM, Inturissi CE. The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions. Pain 1990;43:273-86.
39. Benedetti F, Vighetti S, Amanzio M, et al. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain 1998;74:205-11.
40. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin. JAMA 2005;293:3043-52.
41. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology 1998;50:1837-41.
42. Raja SN, Haythornthwaite JA, Pappagoallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized placebo-controlled trial. Neurology 2002;59:1015-21.
43. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology 2003;60:927-34.
44. Watson CP, Moulin DE, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: A randomized, controlled trial in painful diabetic neuropathy. Pain 2003;105:71-8.
45. Abramowicz M. Tramadol - a new oral analgesic. Med Lett Drugs Ther 37,1995:59-60.
46. Gannon C. The use of methadone in the care of the dying. Eur J Palliat Care 1997;4:152-8.
47. Gagnon B, Almahrezi A, Schreier G. Methadone in the treatment of neuropathic pain. Pain Res Manage 2003;8:149-54.
48. Morley JS, Bridson J, Nash TP, et al. Low dose methadone has an analgesic effect in neuropathic pain: A double-blind randomized controlled crossover trial. Palliat Med 2003;17:576-87.
49. Moulin DE, Palma D, Watling C, et al. Methadone in the management of intractable neuropathic noncancer pain. Can J Neurol Sci 2005;32:340-3.
50. Hocking G, Cousins MJ. Ketamine in chronic pain management: An evidence-based review. Anesth Analg 2003;97:1730-9.
51. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: A randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000;49:574-9.
52. Lynch ME, Clark AJ, Sawynok J, et al. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial. Anesthesiology 2005;103:140-6.
53. Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: A prospective study. J Pain Symptom Manage 1996;12:161-7.
54. Byas-Smith MG, Max MB, Muir J, et al. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage "enriched enrolment" design. Pain 1995;60:267-74.
55. Fromm GH, Terance CF, Chatta AS. Baclofen in the treatment of trigeminal neuralgia. Ann Neurol 1984;15:240-7.
56. Svendsen KB, Jensen TS, Bach FW. The cannabinoid dronabinol reduces central pain in multiple sclerosis. A randomized double-blind, placebo-controlled crossover trial. BMJ 2004;329:253-61.
57. Rog DJ, Nurmikko TJ, Friede T, et al. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005;65:812-9.
58. Leijon G. Boivie J. Central post-stroke pain: A controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27-36.
59. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159:1931-7.
60. Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: Current evidence and future directions. Expert Rev Neurother 2005;5:823-30.
61. Krames E. Implantable devices for pain control: Spinal cord stimulation and intrathecal therapies. Best Pract Res Clin Anaesthesiol 2002;16:619-49.
62. Carter ML. Spinal cord stimulation in chronic pain: A review of the evidence. Anaesth Intensive Care 2004;32:11-21.
63. Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med 2002;347:340-6.
64. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-84.
65. Belfer I, Wu T, Kingman A, Krishnaraju RK, Goldman D, Max MB. Candidate gene studies of human pain mechanisms: Methods for optimizing choice of polymorphisms and sample size. Anesthesiology 2004;100:1562-72.
66. Coull JA, Beggs S, Boudreau D, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005;438:923-5.